Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

We need to improve carers’ skills in diabetes management and technology, writes Martin Scivier As an older person living with diabetes, I am apprehensive about the current and future care of older ...

A literature search was conducted in June 2024 using the PubMed database. The search strategy, detailed in Supplementary Methods S1, combined relevant keywords and Medical Subject Headings (MeSH) ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Education, Labor and Pensions committee hearing. Smith said diabetes patients – especially those with Type 1 – still need insulin. "It seems rather cruel that you would have all these advances ...

In view of the evidence suggesting that insulin resistance and inflammation have a contributing role in the elevated risk for depression in people with type 2 diabetes, the authors expected patients ...

The semaglutide injectables, Ozempic and Wegovy, have been the centre of attention since they launched due to their stronger metabolic effects both on T2D and obesity patients. Credit: fcm82 / ...

Oral semaglutide, sold as Rybelsus, reduced the risk of a group of cardiovascular events by 14% compared with placebo in certain patients with Type 2 diabetes in a late-stage study, Novo said Monday.

The health secretary wants to roll out smartwatches to more members of the public in a bid to tackle debilitating conditions like heart disease and diabetes ... around what patients tell us ...